A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects
Clinical trial NCT02813798 · COMPLETED
Trial details
- NCT number
- NCT02813798
- Sponsor
- GlycoMimetics Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-02-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.